Skip to main content
Figure 2 | Molecular Medicine

Figure 2

From: Designer Monotransregulators Provide a Basis for a Transcriptional Therapy for De Novo Endocrine-Resistant Breast Cancer

Figure 2

Regulation of endogenous gene expression by monotransregulators. MDA-MB-231 cells infected with the adenovirus bearing none (Ad5), ERα or ERαEBD cDNA were treated without (data not shown) or with 10−9 M E2 for 48 h, while cells infected with the adenovirus bearing Ad5-PV or Ad5-PVEBD were treated with vehicle. Total RNA was subjected to qPCR for the analysis of estrogen responsive gene expressions. Results, which are the mean ± SEM of three independent determinations, depict relative change in mRNA levels compared with those observed in cells infected with Ad5 in the absence of E2, which is set to 1. Asterisk (*) indicates significant change.

Back to article page